Abstract:Objective To investigate the effects of Rapamycin, a mammalian target of rapamycin (mTOR) specific inhibitor, on the activation and growth of primordial follicles in mice from the signal transduction of follicular development. Methods A total of 40 C57BL/6 female mice were randomly divided into control group (n=20, same volume of saline) and Rapamycin treatment group (n=20, 5 mg/kg Rapamycin). Seven mice in each group were treated after 30 d, and ovarian histomorphological changes were observed by HE staining, the expressions of DDx4/MVH and Ki-67 were detected by immunohistochemistry, the level of mTOR and its downstream molecules were detected by Western blotting. Eight weeks after administration, 6 mice in control group and Rapamycin treatment group were selected for follicle count, and the expressions of anti-Mullerian hormone (AMH) and Ki-67 were detected by immunohistochemistry. Another 7 mice of both groups were treated with pregnant mare serum gonadotropin (PMSG) and human chorionic gonadotropin (hCG) for ovulation induction. The ovaries were obtained for histomorphological observation by HE staining. Results The number of primordial follicle in Rapamycin treatment group was significantly increased compared with control group (P=0.040), and a large number of primordial follicles were clustered, while the number of growing follicles was significantly decreased(P=0.002). The number of primordial follicle, expressing DDx4/MVH molecule, was increased, while the expression of Ki-67 was decreased compared with control group. Eight weeks after Rapamycin treatment, the number of primordial follicles was still more than that in control group, and the expressions of Ki-67 and AMH in growing follicles were normal. After ovulation induction treatment, large numbers of mature follicles or corpus luteum could be observed in both two groups. Western blotting showed that the phosphorylation levels of mTOR and its downstream molecules p70S6K, rpS6 and eIF4B in Rapamycin treated group were significantly lower than those in control group, while the total molecular level did not change significantly (P>0.05). Conclusion Rapamycin could inhibit the activation of primordial follicles by inhibiting the phosphorylation of mTOR signaling pathway, and slow down the transformation rate of primordial follicles to the growth follicles, and also inhibit the development of growing follicles, thus protect the ovarian reserve function.

Rapamycin-mediated mTOR inhibition impairs silencing of sex chromosomes and the pachytene piRNA pathway in the mouse testis

Alterations of the electrophysiological properties from cortical layer 5 pyramidal neurons in temporary rapamycin-treated rodent brain slices.

Inhibition of mTOR pathway decreases the expression of pre‐meiotic and meiotic markers throughout postnatal development and in adult testes in mice

Conditional ablation of Raptor in the male germline causes infertility due to meiotic arrest and impaired inactivation of sex chromosomes

mTORC1 Activation Promotes Spermatogonial Differentiation and Causes Subfertility in Mice

Rapamycin Inhibits Spermatogenesis by Changing the Autophagy Status Through Suppressing Mechanistic Target of Rapamycin-P70s6 Kinase in Male Rats

Mtor/p70s6k Promotes Spermatogonia Proliferation and Spermatogenesis in Sprague Dawley Rats

Rapamycin and other longevity-promoting compounds enhance the generation of mouse induced pluripotent stem cells.

New Insights into the Role of Mtorc1 in Male Fertility in Zebrafish.

Mechanistic target of rapamycin kinase (Mtor) is required for spermatogonial proliferation and differentiation in mice

Rapamycin Ameliorates Radiation-Induced Testis Damage in Mice

Mammalian target of rapamycin complex 1 (mTORC1) Is required for mouse spermatogonial differentiation in vivo

Rapamycin improves the quality and developmental competence of mice oocytes by promoting DNA damage repair during in vitro maturation

Effects of Rapamycin on the Activation and Growth of Primordial Follicles in Mice

Mtorc1/rps6 Regulates Blood-Testis Barrier Dynamics and Spermatogenetic Function in the Testis in Vivo.

Sex, tissue, and mitochondrial interactions modify the transcriptional response to rapamycin in Drosophila

An Elaborate Regulation of Mammalian Target of Rapamycin Activity is Required for Somatic Cell Reprogramming Induced by Defined Transcription Factors

Long-term treatment of cancer-prone germline PTEN mutant mice with low-dose rapamycin extends lifespan and delays tumour development

mTOR is required for asymmetric division through small GTPases in mouse oocytes

ClpP/ClpX deficiency impairs mitochondrial functions and mTORC1 signaling during spermatogenesis

Mechanistic target of rapamycin (mTOR) pathway in Sertoli cells regulates age-dependent changes in sperm DNA methylation